A Phase II Trial of ZIO-101 in Advanced Multiple Myeloma: Protocol SGL2001b

Record History

See every version on ClinicalTrials.gov ↗

1. Minor Sep 25, 2026 Trial status: Active, Not Recruiting to Completed

   • Primary completion date changed from estimate of Dec 2013 to Dec 21, 2007
   • Study completion date changed from estimate of Dec 2013 to Dec 21, 2008

   v6
2. Minor Nov 13, 2013 Primary and study completion dates: Jun 2013 to Dec 2013v5
3. Notable Jul 18, 2012 Primary and study completion dates: Mar 2008 to Jun 2013

   • Trial status: Completed to Active, Not Recruiting

   v4
4. Minor Jun 26, 2009 Trial status: Active, Not Recruiting to Completed

   • Enrollment target: estimated 40 to confirmed 17
   • Primary and study completion dates changed from estimate of May 2008 to Mar 2008

   v3
5. Minor Dec 26, 2007 Trial status: Not Yet Recruiting to Active, Not Recruitingv2 Show 6 more changesShow less

   • Study sites: 2 to 8
   • Primary and study completion dates: May 2008
   • Start date: Jan 2007
   • Interventions: ZIO-101 (Drug) to Darinaparson (Drug)
   • Eligibility criteria expanded, about 323 words
   • Study arms: 0 to 1
6. Jan 17, 2007 Study First Submitted

• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.